Transgene's market cap is currently €149.61M. The company's EPS TTM is €-0.146; its P/E ratio is ―; Transgene is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
